nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Methotrexate—breast cancer	0.306	1	CrCtD
Pralatrexate—TYMS—breast cancer	0.142	1	CbGaD
Pralatrexate—SLC19A1—Methotrexate—breast cancer	0.0547	0.242	CbGbCtD
Pralatrexate—TYMS—Capecitabine—breast cancer	0.0428	0.189	CbGbCtD
Pralatrexate—Raltitrexed—Methotrexate—breast cancer	0.0404	0.2	CrCrCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—breast cancer	0.0404	0.2	CrCrCtD
Pralatrexate—Pemetrexed—Methotrexate—breast cancer	0.0404	0.2	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—breast cancer	0.0404	0.2	CrCrCtD
Pralatrexate—Leucovorin—Methotrexate—breast cancer	0.0404	0.2	CrCrCtD
Pralatrexate—FPGS—Methotrexate—breast cancer	0.0395	0.175	CbGbCtD
Pralatrexate—TYMS—Gemcitabine—breast cancer	0.0296	0.131	CbGbCtD
Pralatrexate—TYMS—Fluorouracil—breast cancer	0.0254	0.112	CbGbCtD
Pralatrexate—DHFR—Methotrexate—breast cancer	0.0201	0.0888	CbGbCtD
Pralatrexate—TYMS—Methotrexate—breast cancer	0.014	0.0619	CbGbCtD
Pralatrexate—SLC19A1—mammary gland—breast cancer	0.00205	0.101	CbGeAlD
Pralatrexate—FPGS—nipple—breast cancer	0.00113	0.0557	CbGeAlD
Pralatrexate—SLC19A1—adipose tissue—breast cancer	0.000922	0.0455	CbGeAlD
Pralatrexate—SLC19A1—female reproductive system—breast cancer	0.000847	0.0418	CbGeAlD
Pralatrexate—SLC19A1—adrenal gland—breast cancer	0.000827	0.0408	CbGeAlD
Pralatrexate—DHFR—nipple—breast cancer	0.000733	0.0362	CbGeAlD
Pralatrexate—FPGS—skin of body—breast cancer	0.000723	0.0357	CbGeAlD
Pralatrexate—SLC19A1—endocrine gland—breast cancer	0.000717	0.0354	CbGeAlD
Pralatrexate—FPGS—endometrium—breast cancer	0.000681	0.0337	CbGeAlD
Pralatrexate—FPGS—pituitary gland—breast cancer	0.000617	0.0305	CbGeAlD
Pralatrexate—FPGS—adipose tissue—breast cancer	0.000614	0.0303	CbGeAlD
Pralatrexate—DHFR—embryo—breast cancer	0.000605	0.0299	CbGeAlD
Pralatrexate—FPGS—female reproductive system—breast cancer	0.000564	0.0279	CbGeAlD
Pralatrexate—FPGS—adrenal gland—breast cancer	0.000551	0.0272	CbGeAlD
Pralatrexate—FPGS—female gonad—breast cancer	0.000514	0.0254	CbGeAlD
Pralatrexate—Tetrahydrofolic acid—SHMT1—breast cancer	0.000512	0.257	CrCbGaD
Pralatrexate—SLC19A1—lymph node—breast cancer	0.000496	0.0245	CbGeAlD
Pralatrexate—FPGS—endocrine gland—breast cancer	0.000478	0.0236	CbGeAlD
Pralatrexate—TYMS—skin of body—breast cancer	0.000474	0.0234	CbGeAlD
Pralatrexate—TYMS—endometrium—breast cancer	0.000447	0.0221	CbGeAlD
Pralatrexate—DHFR—endometrium—breast cancer	0.000443	0.0219	CbGeAlD
Pralatrexate—DHFR—uterus—breast cancer	0.000408	0.0201	CbGeAlD
Pralatrexate—TYMS—adipose tissue—breast cancer	0.000403	0.0199	CbGeAlD
Pralatrexate—DHFR—pituitary gland—breast cancer	0.0004	0.0198	CbGeAlD
Pralatrexate—DHFR—adipose tissue—breast cancer	0.000399	0.0197	CbGeAlD
Pralatrexate—TYMS—female reproductive system—breast cancer	0.00037	0.0183	CbGeAlD
Pralatrexate—DHFR—female reproductive system—breast cancer	0.000367	0.0181	CbGeAlD
Pralatrexate—TYMS—adrenal gland—breast cancer	0.000361	0.0178	CbGeAlD
Pralatrexate—DHFR—adrenal gland—breast cancer	0.000358	0.0177	CbGeAlD
Pralatrexate—TYMS—bone marrow—breast cancer	0.00035	0.0173	CbGeAlD
Pralatrexate—DHFR—bone marrow—breast cancer	0.000346	0.0171	CbGeAlD
Pralatrexate—TYMS—female gonad—breast cancer	0.000337	0.0166	CbGeAlD
Pralatrexate—DHFR—female gonad—breast cancer	0.000334	0.0165	CbGeAlD
Pralatrexate—FPGS—lymph node—breast cancer	0.00033	0.0163	CbGeAlD
Pralatrexate—TYMS—endocrine gland—breast cancer	0.000313	0.0155	CbGeAlD
Pralatrexate—DHFR—endocrine gland—breast cancer	0.00031	0.0153	CbGeAlD
Pralatrexate—TYMS—Docetaxel—Paclitaxel—breast cancer	0.000284	0.226	CbGdCrCtD
Pralatrexate—TYMS—Gefitinib—Lapatinib—breast cancer	0.000278	0.222	CbGdCrCtD
Pralatrexate—Tetrahydrofolic acid—MTR—breast cancer	0.000262	0.132	CrCbGaD
Pralatrexate—Raltitrexed—TYMS—breast cancer	0.000231	0.116	CrCbGaD
Pralatrexate—TYMS—lymph node—breast cancer	0.000217	0.0107	CbGeAlD
Pralatrexate—DHFR—lymph node—breast cancer	0.000214	0.0106	CbGeAlD
Pralatrexate—Leucovorin—TYMS—breast cancer	0.000175	0.0879	CrCbGaD
Pralatrexate—TYMS—Paclitaxel—Docetaxel—breast cancer	0.000142	0.113	CbGdCrCtD
Pralatrexate—Pemetrexed—TYMS—breast cancer	0.00014	0.0702	CrCbGaD
Pralatrexate—Methotrexate—SLCO1B1—breast cancer	0.000108	0.0542	CrCbGaD
Pralatrexate—TYMS—Vincristine—Vinorelbine—breast cancer	9.74e-05	0.0775	CbGdCrCtD
Pralatrexate—TYMS—Vinorelbine—Vinblastine—breast cancer	9.11e-05	0.0725	CbGdCrCtD
Pralatrexate—Tetrahydrofolic acid—MTHFR—breast cancer	8.97e-05	0.045	CrCbGaD
Pralatrexate—Folic Acid—MTHFR—breast cancer	8.97e-05	0.045	CrCbGaD
Pralatrexate—Methotrexate—ABCC1—breast cancer	8.91e-05	0.0448	CrCbGaD
Pralatrexate—TYMS—Vinblastine—Vinorelbine—breast cancer	7.84e-05	0.0623	CbGdCrCtD
Pralatrexate—TYMS—Vincristine—Vinblastine—breast cancer	7.79e-05	0.062	CbGdCrCtD
Pralatrexate—Methotrexate—TYMS—breast cancer	7.72e-05	0.0387	CrCbGaD
Pralatrexate—Folic Acid—ABCG2—breast cancer	6.87e-05	0.0345	CrCbGaD
Pralatrexate—TYMS—Clobetasol propionate—Fluoxymesterone—breast cancer	6.27e-05	0.0499	CbGdCrCtD
Pralatrexate—Methotrexate—MTHFR—breast cancer	6.14e-05	0.0308	CrCbGaD
Pralatrexate—TYMS—Triamcinolone—Fluoxymesterone—breast cancer	6.13e-05	0.0488	CbGdCrCtD
Pralatrexate—Thrombocytopenia—Mitoxantrone—breast cancer	4.99e-05	0.000983	CcSEcCtD
Pralatrexate—Tachycardia—Mitoxantrone—breast cancer	4.98e-05	0.000979	CcSEcCtD
Pralatrexate—Oedema—Gemcitabine—breast cancer	4.97e-05	0.000978	CcSEcCtD
Pralatrexate—Asthenia—Goserelin—breast cancer	4.95e-05	0.000975	CcSEcCtD
Pralatrexate—Diarrhoea—Tamoxifen—breast cancer	4.95e-05	0.000973	CcSEcCtD
Pralatrexate—Back pain—Paclitaxel—breast cancer	4.93e-05	0.00097	CcSEcCtD
Pralatrexate—Abdominal pain—Vinorelbine—breast cancer	4.89e-05	0.000962	CcSEcCtD
Pralatrexate—Body temperature increased—Vinorelbine—breast cancer	4.89e-05	0.000962	CcSEcCtD
Pralatrexate—Pruritus—Goserelin—breast cancer	4.88e-05	0.000961	CcSEcCtD
Pralatrexate—Oedema—Fluorouracil—breast cancer	4.88e-05	0.000961	CcSEcCtD
Pralatrexate—Thrombocytopenia—Gemcitabine—breast cancer	4.86e-05	0.000957	CcSEcCtD
Pralatrexate—Anorexia—Irinotecan—breast cancer	4.86e-05	0.000957	CcSEcCtD
Pralatrexate—Anorexia—Mitoxantrone—breast cancer	4.86e-05	0.000957	CcSEcCtD
Pralatrexate—Diarrhoea—Melphalan—breast cancer	4.84e-05	0.000953	CcSEcCtD
Pralatrexate—Pain in extremity—Epirubicin—breast cancer	4.84e-05	0.000952	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Thiotepa—breast cancer	4.83e-05	0.00095	CcSEcCtD
Pralatrexate—Nausea—Chlorambucil—breast cancer	4.82e-05	0.000949	CcSEcCtD
Pralatrexate—Thrombocytopenia—Fluorouracil—breast cancer	4.78e-05	0.000941	CcSEcCtD
Pralatrexate—Liver function test abnormal—Methotrexate—breast cancer	4.77e-05	0.000939	CcSEcCtD
Pralatrexate—Tachycardia—Fluorouracil—breast cancer	4.77e-05	0.000938	CcSEcCtD
Pralatrexate—TYMS—Danazol—Fluoxymesterone—breast cancer	4.75e-05	0.0377	CbGdCrCtD
Pralatrexate—Anorexia—Gemcitabine—breast cancer	4.73e-05	0.000932	CcSEcCtD
Pralatrexate—Vomiting—Vinblastine—breast cancer	4.73e-05	0.000931	CcSEcCtD
Pralatrexate—Diarrhoea—Goserelin—breast cancer	4.72e-05	0.00093	CcSEcCtD
Pralatrexate—Anaemia—Paclitaxel—breast cancer	4.71e-05	0.000927	CcSEcCtD
Pralatrexate—Methotrexate—ABCG2—breast cancer	4.7e-05	0.0236	CrCbGaD
Pralatrexate—Body temperature increased—Thiotepa—breast cancer	4.67e-05	0.000919	CcSEcCtD
Pralatrexate—Abdominal pain—Thiotepa—breast cancer	4.67e-05	0.000919	CcSEcCtD
Pralatrexate—Anorexia—Fluorouracil—breast cancer	4.66e-05	0.000916	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methotrexate—breast cancer	4.65e-05	0.000916	CcSEcCtD
Pralatrexate—Vomiting—Tamoxifen—breast cancer	4.6e-05	0.000904	CcSEcCtD
Pralatrexate—Leukopenia—Paclitaxel—breast cancer	4.56e-05	0.000898	CcSEcCtD
Pralatrexate—Rash—Tamoxifen—breast cancer	4.56e-05	0.000897	CcSEcCtD
Pralatrexate—Dermatitis—Tamoxifen—breast cancer	4.55e-05	0.000896	CcSEcCtD
Pralatrexate—Dyspnoea—Mitoxantrone—breast cancer	4.55e-05	0.000895	CcSEcCtD
Pralatrexate—Dyspnoea—Irinotecan—breast cancer	4.55e-05	0.000895	CcSEcCtD
Pralatrexate—Vomiting—Melphalan—breast cancer	4.5e-05	0.000886	CcSEcCtD
Pralatrexate—Dehydration—Epirubicin—breast cancer	4.5e-05	0.000885	CcSEcCtD
Pralatrexate—Pain in extremity—Doxorubicin—breast cancer	4.48e-05	0.000881	CcSEcCtD
Pralatrexate—Liver function test abnormal—Epirubicin—breast cancer	4.47e-05	0.000879	CcSEcCtD
Pralatrexate—Rash—Melphalan—breast cancer	4.46e-05	0.000878	CcSEcCtD
Pralatrexate—Dermatitis—Melphalan—breast cancer	4.46e-05	0.000877	CcSEcCtD
Pralatrexate—Cough—Paclitaxel—breast cancer	4.45e-05	0.000875	CcSEcCtD
Pralatrexate—Asthenia—Vinorelbine—breast cancer	4.44e-05	0.000873	CcSEcCtD
Pralatrexate—Decreased appetite—Mitoxantrone—breast cancer	4.43e-05	0.000872	CcSEcCtD
Pralatrexate—Decreased appetite—Irinotecan—breast cancer	4.43e-05	0.000872	CcSEcCtD
Pralatrexate—Dyspnoea—Gemcitabine—breast cancer	4.43e-05	0.000872	CcSEcCtD
Pralatrexate—Nausea—Vinblastine—breast cancer	4.42e-05	0.00087	CcSEcCtD
Pralatrexate—Hypokalaemia—Epirubicin—breast cancer	4.4e-05	0.000866	CcSEcCtD
Pralatrexate—Fatigue—Irinotecan—breast cancer	4.4e-05	0.000865	CcSEcCtD
Pralatrexate—Fatigue—Mitoxantrone—breast cancer	4.4e-05	0.000865	CcSEcCtD
Pralatrexate—Vomiting—Goserelin—breast cancer	4.39e-05	0.000864	CcSEcCtD
Pralatrexate—Pruritus—Vinorelbine—breast cancer	4.37e-05	0.000861	CcSEcCtD
Pralatrexate—Constipation—Mitoxantrone—breast cancer	4.36e-05	0.000858	CcSEcCtD
Pralatrexate—Constipation—Irinotecan—breast cancer	4.36e-05	0.000858	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Epirubicin—breast cancer	4.36e-05	0.000857	CcSEcCtD
Pralatrexate—Dyspnoea—Fluorouracil—breast cancer	4.35e-05	0.000857	CcSEcCtD
Pralatrexate—Rash—Goserelin—breast cancer	4.35e-05	0.000857	CcSEcCtD
Pralatrexate—Dermatitis—Goserelin—breast cancer	4.35e-05	0.000856	CcSEcCtD
Pralatrexate—Decreased appetite—Gemcitabine—breast cancer	4.32e-05	0.00085	CcSEcCtD
Pralatrexate—Nausea—Tamoxifen—breast cancer	4.29e-05	0.000845	CcSEcCtD
Pralatrexate—Fatigue—Gemcitabine—breast cancer	4.28e-05	0.000843	CcSEcCtD
Pralatrexate—Constipation—Gemcitabine—breast cancer	4.25e-05	0.000836	CcSEcCtD
Pralatrexate—Decreased appetite—Fluorouracil—breast cancer	4.25e-05	0.000836	CcSEcCtD
Pralatrexate—Pancytopenia—Methotrexate—breast cancer	4.24e-05	0.000835	CcSEcCtD
Pralatrexate—Asthenia—Thiotepa—breast cancer	4.24e-05	0.000834	CcSEcCtD
Pralatrexate—Diarrhoea—Vinorelbine—breast cancer	4.23e-05	0.000833	CcSEcCtD
Pralatrexate—Nausea—Melphalan—breast cancer	4.2e-05	0.000827	CcSEcCtD
Pralatrexate—Back pain—Docetaxel—breast cancer	4.18e-05	0.000822	CcSEcCtD
Pralatrexate—Neutropenia—Methotrexate—breast cancer	4.18e-05	0.000822	CcSEcCtD
Pralatrexate—Pruritus—Thiotepa—breast cancer	4.18e-05	0.000822	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Mitoxantrone—breast cancer	4.17e-05	0.000821	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Irinotecan—breast cancer	4.17e-05	0.000821	CcSEcCtD
Pralatrexate—Dehydration—Doxorubicin—breast cancer	4.16e-05	0.000819	CcSEcCtD
Pralatrexate—Oedema—Paclitaxel—breast cancer	4.16e-05	0.000818	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—breast cancer	4.15e-05	0.000817	CcSEcCtD
Pralatrexate—Liver function test abnormal—Doxorubicin—breast cancer	4.13e-05	0.000813	CcSEcCtD
Pralatrexate—Nausea—Goserelin—breast cancer	4.1e-05	0.000807	CcSEcCtD
Pralatrexate—Hypokalaemia—Doxorubicin—breast cancer	4.07e-05	0.000802	CcSEcCtD
Pralatrexate—Thrombocytopenia—Paclitaxel—breast cancer	4.07e-05	0.000801	CcSEcCtD
Pralatrexate—Tachycardia—Paclitaxel—breast cancer	4.06e-05	0.000799	CcSEcCtD
Pralatrexate—Back pain—Capecitabine—breast cancer	4.04e-05	0.000796	CcSEcCtD
Pralatrexate—Diarrhoea—Thiotepa—breast cancer	4.04e-05	0.000795	CcSEcCtD
Pralatrexate—Body temperature increased—Irinotecan—breast cancer	4.03e-05	0.000793	CcSEcCtD
Pralatrexate—Body temperature increased—Mitoxantrone—breast cancer	4.03e-05	0.000793	CcSEcCtD
Pralatrexate—Abdominal pain—Irinotecan—breast cancer	4.03e-05	0.000793	CcSEcCtD
Pralatrexate—Abdominal pain—Mitoxantrone—breast cancer	4.03e-05	0.000793	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Doxorubicin—breast cancer	4.03e-05	0.000793	CcSEcCtD
Pralatrexate—Anaemia—Docetaxel—breast cancer	3.99e-05	0.000786	CcSEcCtD
Pralatrexate—Pancytopenia—Epirubicin—breast cancer	3.97e-05	0.000781	CcSEcCtD
Pralatrexate—Anorexia—Paclitaxel—breast cancer	3.96e-05	0.00078	CcSEcCtD
Pralatrexate—Vomiting—Vinorelbine—breast cancer	3.93e-05	0.000774	CcSEcCtD
Pralatrexate—Body temperature increased—Gemcitabine—breast cancer	3.93e-05	0.000773	CcSEcCtD
Pralatrexate—Neutropenia—Epirubicin—breast cancer	3.91e-05	0.000769	CcSEcCtD
Pralatrexate—Rash—Vinorelbine—breast cancer	3.9e-05	0.000767	CcSEcCtD
Pralatrexate—Dermatitis—Vinorelbine—breast cancer	3.89e-05	0.000767	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Epirubicin—breast cancer	3.89e-05	0.000765	CcSEcCtD
Pralatrexate—Leukopenia—Docetaxel—breast cancer	3.87e-05	0.000761	CcSEcCtD
Pralatrexate—Anaemia—Capecitabine—breast cancer	3.86e-05	0.000761	CcSEcCtD
Pralatrexate—Body temperature increased—Fluorouracil—breast cancer	3.86e-05	0.00076	CcSEcCtD
Pralatrexate—Cough—Docetaxel—breast cancer	3.77e-05	0.000742	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—breast cancer	3.76e-05	0.000739	CcSEcCtD
Pralatrexate—Vomiting—Thiotepa—breast cancer	3.75e-05	0.000739	CcSEcCtD
Pralatrexate—Leukopenia—Capecitabine—breast cancer	3.74e-05	0.000737	CcSEcCtD
Pralatrexate—Rash—Thiotepa—breast cancer	3.72e-05	0.000733	CcSEcCtD
Pralatrexate—Dermatitis—Thiotepa—breast cancer	3.72e-05	0.000732	CcSEcCtD
Pralatrexate—Dyspnoea—Paclitaxel—breast cancer	3.71e-05	0.00073	CcSEcCtD
Pralatrexate—Pancytopenia—Doxorubicin—breast cancer	3.67e-05	0.000723	CcSEcCtD
Pralatrexate—Nausea—Vinorelbine—breast cancer	3.67e-05	0.000723	CcSEcCtD
Pralatrexate—TYMS—Azacitidine—Gemcitabine—breast cancer	3.67e-05	0.0292	CbGdCrCtD
Pralatrexate—Asthenia—Mitoxantrone—breast cancer	3.66e-05	0.00072	CcSEcCtD
Pralatrexate—Asthenia—Irinotecan—breast cancer	3.66e-05	0.00072	CcSEcCtD
Pralatrexate—Cough—Capecitabine—breast cancer	3.65e-05	0.000718	CcSEcCtD
Pralatrexate—Neutropenia—Doxorubicin—breast cancer	3.62e-05	0.000712	CcSEcCtD
Pralatrexate—Decreased appetite—Paclitaxel—breast cancer	3.61e-05	0.000711	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Doxorubicin—breast cancer	3.6e-05	0.000708	CcSEcCtD
Pralatrexate—Fatigue—Paclitaxel—breast cancer	3.59e-05	0.000706	CcSEcCtD
Pralatrexate—Asthenia—Gemcitabine—breast cancer	3.56e-05	0.000701	CcSEcCtD
Pralatrexate—Constipation—Paclitaxel—breast cancer	3.56e-05	0.0007	CcSEcCtD
Pralatrexate—Oedema—Docetaxel—breast cancer	3.52e-05	0.000694	CcSEcCtD
Pralatrexate—Epistaxis—Epirubicin—breast cancer	3.52e-05	0.000692	CcSEcCtD
Pralatrexate—Pruritus—Gemcitabine—breast cancer	3.51e-05	0.000692	CcSEcCtD
Pralatrexate—Nausea—Thiotepa—breast cancer	3.51e-05	0.00069	CcSEcCtD
Pralatrexate—Diarrhoea—Mitoxantrone—breast cancer	3.49e-05	0.000687	CcSEcCtD
Pralatrexate—Diarrhoea—Irinotecan—breast cancer	3.49e-05	0.000687	CcSEcCtD
Pralatrexate—Pruritus—Fluorouracil—breast cancer	3.46e-05	0.00068	CcSEcCtD
Pralatrexate—Thrombocytopenia—Docetaxel—breast cancer	3.45e-05	0.000679	CcSEcCtD
Pralatrexate—Tachycardia—Docetaxel—breast cancer	3.44e-05	0.000677	CcSEcCtD
Pralatrexate—Oedema—Capecitabine—breast cancer	3.41e-05	0.000672	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Paclitaxel—breast cancer	3.4e-05	0.000669	CcSEcCtD
Pralatrexate—Diarrhoea—Gemcitabine—breast cancer	3.4e-05	0.000669	CcSEcCtD
Pralatrexate—Anorexia—Docetaxel—breast cancer	3.36e-05	0.000661	CcSEcCtD
Pralatrexate—Diarrhoea—Fluorouracil—breast cancer	3.34e-05	0.000658	CcSEcCtD
Pralatrexate—Thrombocytopenia—Capecitabine—breast cancer	3.34e-05	0.000658	CcSEcCtD
Pralatrexate—Tachycardia—Capecitabine—breast cancer	3.33e-05	0.000656	CcSEcCtD
Pralatrexate—Abdominal pain—Paclitaxel—breast cancer	3.29e-05	0.000647	CcSEcCtD
Pralatrexate—Body temperature increased—Paclitaxel—breast cancer	3.29e-05	0.000647	CcSEcCtD
Pralatrexate—Epistaxis—Doxorubicin—breast cancer	3.25e-05	0.00064	CcSEcCtD
Pralatrexate—Anorexia—Capecitabine—breast cancer	3.25e-05	0.00064	CcSEcCtD
Pralatrexate—Vomiting—Mitoxantrone—breast cancer	3.24e-05	0.000638	CcSEcCtD
Pralatrexate—Vomiting—Irinotecan—breast cancer	3.24e-05	0.000638	CcSEcCtD
Pralatrexate—Rash—Mitoxantrone—breast cancer	3.22e-05	0.000633	CcSEcCtD
Pralatrexate—Rash—Irinotecan—breast cancer	3.22e-05	0.000633	CcSEcCtD
Pralatrexate—Dermatitis—Mitoxantrone—breast cancer	3.21e-05	0.000632	CcSEcCtD
Pralatrexate—Dermatitis—Irinotecan—breast cancer	3.21e-05	0.000632	CcSEcCtD
Pralatrexate—Vomiting—Gemcitabine—breast cancer	3.16e-05	0.000622	CcSEcCtD
Pralatrexate—Dyspnoea—Docetaxel—breast cancer	3.14e-05	0.000618	CcSEcCtD
Pralatrexate—Rash—Gemcitabine—breast cancer	3.13e-05	0.000616	CcSEcCtD
Pralatrexate—Dermatitis—Gemcitabine—breast cancer	3.13e-05	0.000616	CcSEcCtD
Pralatrexate—Vomiting—Fluorouracil—breast cancer	3.11e-05	0.000611	CcSEcCtD
Pralatrexate—Rash—Fluorouracil—breast cancer	3.08e-05	0.000606	CcSEcCtD
Pralatrexate—Dermatitis—Fluorouracil—breast cancer	3.08e-05	0.000605	CcSEcCtD
Pralatrexate—Decreased appetite—Docetaxel—breast cancer	3.06e-05	0.000603	CcSEcCtD
Pralatrexate—Dyspnoea—Capecitabine—breast cancer	3.04e-05	0.000599	CcSEcCtD
Pralatrexate—Fatigue—Docetaxel—breast cancer	3.04e-05	0.000598	CcSEcCtD
Pralatrexate—Nausea—Mitoxantrone—breast cancer	3.03e-05	0.000596	CcSEcCtD
Pralatrexate—Nausea—Irinotecan—breast cancer	3.03e-05	0.000596	CcSEcCtD
Pralatrexate—Constipation—Docetaxel—breast cancer	3.01e-05	0.000593	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—breast cancer	3.01e-05	0.000593	CcSEcCtD
Pralatrexate—Asthenia—Paclitaxel—breast cancer	2.98e-05	0.000587	CcSEcCtD
Pralatrexate—Decreased appetite—Capecitabine—breast cancer	2.97e-05	0.000584	CcSEcCtD
Pralatrexate—Nausea—Gemcitabine—breast cancer	2.95e-05	0.000581	CcSEcCtD
Pralatrexate—Fatigue—Capecitabine—breast cancer	2.94e-05	0.000579	CcSEcCtD
Pralatrexate—Pruritus—Paclitaxel—breast cancer	2.94e-05	0.000579	CcSEcCtD
Pralatrexate—Constipation—Capecitabine—breast cancer	2.92e-05	0.000574	CcSEcCtD
Pralatrexate—Nausea—Fluorouracil—breast cancer	2.9e-05	0.000571	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Docetaxel—breast cancer	2.88e-05	0.000567	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—breast cancer	2.88e-05	0.000566	CcSEcCtD
Pralatrexate—Diarrhoea—Paclitaxel—breast cancer	2.85e-05	0.00056	CcSEcCtD
Pralatrexate—Back pain—Epirubicin—breast cancer	2.82e-05	0.000555	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Capecitabine—breast cancer	2.79e-05	0.000549	CcSEcCtD
Pralatrexate—Body temperature increased—Docetaxel—breast cancer	2.79e-05	0.000548	CcSEcCtD
Pralatrexate—Abdominal pain—Docetaxel—breast cancer	2.79e-05	0.000548	CcSEcCtD
Pralatrexate—Leukopenia—Methotrexate—breast cancer	2.79e-05	0.000548	CcSEcCtD
Pralatrexate—Cough—Methotrexate—breast cancer	2.72e-05	0.000535	CcSEcCtD
Pralatrexate—Abdominal pain—Capecitabine—breast cancer	2.7e-05	0.000531	CcSEcCtD
Pralatrexate—Body temperature increased—Capecitabine—breast cancer	2.7e-05	0.000531	CcSEcCtD
Pralatrexate—Anaemia—Epirubicin—breast cancer	2.69e-05	0.00053	CcSEcCtD
Pralatrexate—Vomiting—Paclitaxel—breast cancer	2.64e-05	0.00052	CcSEcCtD
Pralatrexate—Rash—Paclitaxel—breast cancer	2.62e-05	0.000516	CcSEcCtD
Pralatrexate—Dermatitis—Paclitaxel—breast cancer	2.62e-05	0.000516	CcSEcCtD
Pralatrexate—Leukopenia—Epirubicin—breast cancer	2.61e-05	0.000513	CcSEcCtD
Pralatrexate—Back pain—Doxorubicin—breast cancer	2.61e-05	0.000513	CcSEcCtD
Pralatrexate—Cough—Epirubicin—breast cancer	2.54e-05	0.0005	CcSEcCtD
Pralatrexate—Asthenia—Docetaxel—breast cancer	2.53e-05	0.000498	CcSEcCtD
Pralatrexate—Pruritus—Docetaxel—breast cancer	2.49e-05	0.000491	CcSEcCtD
Pralatrexate—Anaemia—Doxorubicin—breast cancer	2.49e-05	0.00049	CcSEcCtD
Pralatrexate—Thrombocytopenia—Methotrexate—breast cancer	2.49e-05	0.00049	CcSEcCtD
Pralatrexate—Nausea—Paclitaxel—breast cancer	2.47e-05	0.000486	CcSEcCtD
Pralatrexate—Asthenia—Capecitabine—breast cancer	2.45e-05	0.000482	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—breast cancer	2.42e-05	0.000477	CcSEcCtD
Pralatrexate—Pruritus—Capecitabine—breast cancer	2.41e-05	0.000475	CcSEcCtD
Pralatrexate—Leukopenia—Doxorubicin—breast cancer	2.41e-05	0.000475	CcSEcCtD
Pralatrexate—Diarrhoea—Docetaxel—breast cancer	2.41e-05	0.000475	CcSEcCtD
Pralatrexate—Oedema—Epirubicin—breast cancer	2.38e-05	0.000468	CcSEcCtD
Pralatrexate—Cough—Doxorubicin—breast cancer	2.35e-05	0.000463	CcSEcCtD
Pralatrexate—Diarrhoea—Capecitabine—breast cancer	2.33e-05	0.00046	CcSEcCtD
Pralatrexate—Thrombocytopenia—Epirubicin—breast cancer	2.33e-05	0.000458	CcSEcCtD
Pralatrexate—Tachycardia—Epirubicin—breast cancer	2.32e-05	0.000457	CcSEcCtD
Pralatrexate—Anorexia—Epirubicin—breast cancer	2.27e-05	0.000446	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—breast cancer	2.26e-05	0.000446	CcSEcCtD
Pralatrexate—Vomiting—Docetaxel—breast cancer	2.24e-05	0.000441	CcSEcCtD
Pralatrexate—Rash—Docetaxel—breast cancer	2.22e-05	0.000437	CcSEcCtD
Pralatrexate—Dermatitis—Docetaxel—breast cancer	2.22e-05	0.000437	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—breast cancer	2.21e-05	0.000435	CcSEcCtD
Pralatrexate—Oedema—Doxorubicin—breast cancer	2.2e-05	0.000433	CcSEcCtD
Pralatrexate—Fatigue—Methotrexate—breast cancer	2.19e-05	0.000431	CcSEcCtD
Pralatrexate—Vomiting—Capecitabine—breast cancer	2.17e-05	0.000427	CcSEcCtD
Pralatrexate—Thrombocytopenia—Doxorubicin—breast cancer	2.15e-05	0.000424	CcSEcCtD
Pralatrexate—Rash—Capecitabine—breast cancer	2.15e-05	0.000424	CcSEcCtD
Pralatrexate—Dermatitis—Capecitabine—breast cancer	2.15e-05	0.000423	CcSEcCtD
Pralatrexate—Tachycardia—Doxorubicin—breast cancer	2.15e-05	0.000423	CcSEcCtD
Pralatrexate—Dyspnoea—Epirubicin—breast cancer	2.12e-05	0.000417	CcSEcCtD
Pralatrexate—Anorexia—Doxorubicin—breast cancer	2.1e-05	0.000413	CcSEcCtD
Pralatrexate—Nausea—Docetaxel—breast cancer	2.09e-05	0.000412	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—breast cancer	2.08e-05	0.000409	CcSEcCtD
Pralatrexate—Decreased appetite—Epirubicin—breast cancer	2.07e-05	0.000407	CcSEcCtD
Pralatrexate—Fatigue—Epirubicin—breast cancer	2.05e-05	0.000403	CcSEcCtD
Pralatrexate—Methotrexate—ALB—breast cancer	2.05e-05	0.0103	CrCbGaD
Pralatrexate—Constipation—Epirubicin—breast cancer	2.03e-05	0.0004	CcSEcCtD
Pralatrexate—Nausea—Capecitabine—breast cancer	2.03e-05	0.000399	CcSEcCtD
Pralatrexate—Abdominal pain—Methotrexate—breast cancer	2.01e-05	0.000395	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—breast cancer	2.01e-05	0.000395	CcSEcCtD
Pralatrexate—Dyspnoea—Doxorubicin—breast cancer	1.96e-05	0.000386	CcSEcCtD
Pralatrexate—Methotrexate—ABCB1—breast cancer	1.96e-05	0.00982	CrCbGaD
Pralatrexate—Gastrointestinal pain—Epirubicin—breast cancer	1.94e-05	0.000383	CcSEcCtD
Pralatrexate—Decreased appetite—Doxorubicin—breast cancer	1.91e-05	0.000376	CcSEcCtD
Pralatrexate—Fatigue—Doxorubicin—breast cancer	1.9e-05	0.000373	CcSEcCtD
Pralatrexate—Constipation—Doxorubicin—breast cancer	1.88e-05	0.00037	CcSEcCtD
Pralatrexate—Abdominal pain—Epirubicin—breast cancer	1.88e-05	0.00037	CcSEcCtD
Pralatrexate—Body temperature increased—Epirubicin—breast cancer	1.88e-05	0.00037	CcSEcCtD
Pralatrexate—Asthenia—Methotrexate—breast cancer	1.82e-05	0.000359	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Doxorubicin—breast cancer	1.8e-05	0.000354	CcSEcCtD
Pralatrexate—Pruritus—Methotrexate—breast cancer	1.8e-05	0.000354	CcSEcCtD
Pralatrexate—Body temperature increased—Doxorubicin—breast cancer	1.74e-05	0.000342	CcSEcCtD
Pralatrexate—Abdominal pain—Doxorubicin—breast cancer	1.74e-05	0.000342	CcSEcCtD
Pralatrexate—Diarrhoea—Methotrexate—breast cancer	1.74e-05	0.000342	CcSEcCtD
Pralatrexate—Asthenia—Epirubicin—breast cancer	1.71e-05	0.000336	CcSEcCtD
Pralatrexate—Pruritus—Epirubicin—breast cancer	1.68e-05	0.000331	CcSEcCtD
Pralatrexate—Diarrhoea—Epirubicin—breast cancer	1.63e-05	0.00032	CcSEcCtD
Pralatrexate—Vomiting—Methotrexate—breast cancer	1.62e-05	0.000318	CcSEcCtD
Pralatrexate—Rash—Methotrexate—breast cancer	1.6e-05	0.000315	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—breast cancer	1.6e-05	0.000315	CcSEcCtD
Pralatrexate—Asthenia—Doxorubicin—breast cancer	1.58e-05	0.000311	CcSEcCtD
Pralatrexate—Pruritus—Doxorubicin—breast cancer	1.56e-05	0.000306	CcSEcCtD
Pralatrexate—Vomiting—Epirubicin—breast cancer	1.51e-05	0.000298	CcSEcCtD
Pralatrexate—Nausea—Methotrexate—breast cancer	1.51e-05	0.000297	CcSEcCtD
Pralatrexate—Diarrhoea—Doxorubicin—breast cancer	1.51e-05	0.000296	CcSEcCtD
Pralatrexate—Rash—Epirubicin—breast cancer	1.5e-05	0.000295	CcSEcCtD
Pralatrexate—Dermatitis—Epirubicin—breast cancer	1.5e-05	0.000295	CcSEcCtD
Pralatrexate—Nausea—Epirubicin—breast cancer	1.41e-05	0.000278	CcSEcCtD
Pralatrexate—Vomiting—Doxorubicin—breast cancer	1.4e-05	0.000275	CcSEcCtD
Pralatrexate—Rash—Doxorubicin—breast cancer	1.39e-05	0.000273	CcSEcCtD
Pralatrexate—Dermatitis—Doxorubicin—breast cancer	1.39e-05	0.000273	CcSEcCtD
Pralatrexate—Nausea—Doxorubicin—breast cancer	1.31e-05	0.000257	CcSEcCtD
Pralatrexate—DHFR—Disease—ENO1—breast cancer	7.64e-06	0.000156	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALDOA—breast cancer	7.6e-06	0.000155	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—breast cancer	7.55e-06	0.000154	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOA3—breast cancer	7.38e-06	0.000151	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CTNNB1—breast cancer	7.38e-06	0.000151	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK2—breast cancer	7.37e-06	0.000151	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A2—breast cancer	7.33e-06	0.00015	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—breast cancer	7.27e-06	0.000148	CbGpPWpGaD
Pralatrexate—FPGS—Disease—RAF1—breast cancer	7.25e-06	0.000148	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF3—breast cancer	7.23e-06	0.000148	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—breast cancer	7.21e-06	0.000147	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTEN—breast cancer	7.19e-06	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTR—breast cancer	7.18e-06	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CPT1A—breast cancer	7.18e-06	0.000147	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCG2—breast cancer	7.18e-06	0.000147	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ERBB2—breast cancer	7.17e-06	0.000146	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FASN—breast cancer	7.13e-06	0.000146	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAG1—breast cancer	7.13e-06	0.000146	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PARP1—breast cancer	7.1e-06	0.000145	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	7.08e-06	0.000145	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CB—breast cancer	7.07e-06	0.000144	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTOR—breast cancer	7.07e-06	0.000144	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—breast cancer	7.06e-06	0.000144	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HPGDS—breast cancer	7.04e-06	0.000144	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CALCA—breast cancer	7.02e-06	0.000143	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—breast cancer	7.01e-06	0.000143	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—ATM—breast cancer	7e-06	0.000143	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HBA1—breast cancer	7e-06	0.000143	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK4—breast cancer	6.97e-06	0.000142	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CB—breast cancer	6.97e-06	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—breast cancer	6.94e-06	0.000142	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RPS6—breast cancer	6.93e-06	0.000142	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—breast cancer	6.9e-06	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF4—breast cancer	6.88e-06	0.000141	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CXCR4—breast cancer	6.85e-06	0.00014	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	6.85e-06	0.00014	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—breast cancer	6.83e-06	0.000139	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ACHE—breast cancer	6.83e-06	0.000139	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CD—breast cancer	6.8e-06	0.000139	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—breast cancer	6.78e-06	0.000138	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SLC2A1—breast cancer	6.78e-06	0.000138	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MED12—breast cancer	6.74e-06	0.000138	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—DPYD—breast cancer	6.74e-06	0.000138	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—breast cancer	6.71e-06	0.000137	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SRC—breast cancer	6.67e-06	0.000136	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—breast cancer	6.64e-06	0.000136	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALDOA—breast cancer	6.63e-06	0.000135	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TCF7L2—breast cancer	6.61e-06	0.000135	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—breast cancer	6.57e-06	0.000134	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP17A1—breast cancer	6.46e-06	0.000132	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA3—breast cancer	6.44e-06	0.000132	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—breast cancer	6.43e-06	0.000131	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—breast cancer	6.42e-06	0.000131	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO1—breast cancer	6.4e-06	0.000131	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS1—breast cancer	6.4e-06	0.000131	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A2—breast cancer	6.39e-06	0.000131	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HSP90AA1—breast cancer	6.37e-06	0.00013	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP2D6—breast cancer	6.28e-06	0.000128	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CTNNB1—breast cancer	6.27e-06	0.000128	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTR—breast cancer	6.26e-06	0.000128	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CPT1A—breast cancer	6.26e-06	0.000128	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCG2—breast cancer	6.26e-06	0.000128	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRL—breast cancer	6.2e-06	0.000127	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOA2—breast cancer	6.16e-06	0.000126	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HPGDS—breast cancer	6.14e-06	0.000125	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK3—breast cancer	6.14e-06	0.000125	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—breast cancer	6.13e-06	0.000125	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—breast cancer	6.11e-06	0.000125	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ADAM10—breast cancer	6.11e-06	0.000125	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HBA1—breast cancer	6.1e-06	0.000125	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—breast cancer	6.06e-06	0.000124	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—breast cancer	6.05e-06	0.000123	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—breast cancer	6.02e-06	0.000123	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—breast cancer	6.02e-06	0.000123	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—breast cancer	5.97e-06	0.000122	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—FASN—breast cancer	5.97e-06	0.000122	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—breast cancer	5.96e-06	0.000122	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ACHE—breast cancer	5.96e-06	0.000122	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—breast cancer	5.96e-06	0.000122	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—BCHE—breast cancer	5.95e-06	0.000121	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF10—breast cancer	5.94e-06	0.000121	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CB—breast cancer	5.92e-06	0.000121	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—breast cancer	5.92e-06	0.000121	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC5A5—breast cancer	5.88e-06	0.00012	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—breast cancer	5.87e-06	0.00012	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—breast cancer	5.84e-06	0.000119	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	5.78e-06	0.000118	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—breast cancer	5.77e-06	0.000118	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFA—breast cancer	5.73e-06	0.000117	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC2A1—breast cancer	5.67e-06	0.000116	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NQO1—breast cancer	5.67e-06	0.000116	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SRC—breast cancer	5.67e-06	0.000116	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFBR2—breast cancer	5.65e-06	0.000115	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP17A1—breast cancer	5.64e-06	0.000115	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS1—breast cancer	5.58e-06	0.000114	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO1—breast cancer	5.58e-06	0.000114	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—breast cancer	5.58e-06	0.000114	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ITPR1—breast cancer	5.56e-06	0.000114	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP3A4—breast cancer	5.53e-06	0.000113	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB4—breast cancer	5.52e-06	0.000113	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT5A—breast cancer	5.52e-06	0.000113	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—breast cancer	5.52e-06	0.000113	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP2D6—breast cancer	5.48e-06	0.000112	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—breast cancer	5.47e-06	0.000112	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1B1—breast cancer	5.44e-06	0.000111	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—breast cancer	5.41e-06	0.00011	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA2—breast cancer	5.37e-06	0.00011	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SMAD4—breast cancer	5.35e-06	0.000109	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HSP90AA1—breast cancer	5.34e-06	0.000109	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—breast cancer	5.28e-06	0.000108	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—breast cancer	5.22e-06	0.000107	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK3—breast cancer	5.22e-06	0.000107	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—FASN—breast cancer	5.21e-06	0.000106	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NCOR1—breast cancer	5.19e-06	0.000106	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—BCHE—breast cancer	5.19e-06	0.000106	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOA1—breast cancer	5.19e-06	0.000106	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—breast cancer	5.17e-06	0.000106	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—breast cancer	5.16e-06	0.000105	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF1—breast cancer	5.14e-06	0.000105	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC5A5—breast cancer	5.13e-06	0.000105	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—breast cancer	5.12e-06	0.000105	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—STK11—breast cancer	5.12e-06	0.000104	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP19A1—breast cancer	5.12e-06	0.000104	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NRG1—breast cancer	5.1e-06	0.000104	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—breast cancer	5.08e-06	0.000104	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—breast cancer	5.07e-06	0.000104	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—breast cancer	5.07e-06	0.000103	CbGpPWpGaD
Pralatrexate—DHFR—Disease—H2AFX—breast cancer	5.06e-06	0.000103	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—breast cancer	5.03e-06	0.000103	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—breast cancer	4.99e-06	0.000102	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—breast cancer	4.97e-06	0.000101	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NQO1—breast cancer	4.95e-06	0.000101	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC2A1—breast cancer	4.95e-06	0.000101	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERCC2—breast cancer	4.88e-06	9.97e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—breast cancer	4.87e-06	9.94e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP3A4—breast cancer	4.83e-06	9.86e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB3—breast cancer	4.78e-06	9.75e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR2—breast cancer	4.77e-06	9.74e-05	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK3—breast cancer	4.76e-06	9.71e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—COMT—breast cancer	4.76e-06	9.71e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1B1—breast cancer	4.75e-06	9.7e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—breast cancer	4.73e-06	9.67e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—breast cancer	4.72e-06	9.63e-05	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—breast cancer	4.69e-06	9.59e-05	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—breast cancer	4.69e-06	9.58e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HMOX1—breast cancer	4.67e-06	9.53e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ITPR1—breast cancer	4.66e-06	9.51e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSP90AA1—breast cancer	4.66e-06	9.51e-05	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—breast cancer	4.63e-06	9.45e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—breast cancer	4.59e-06	9.37e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—breast cancer	4.58e-06	9.35e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA1—breast cancer	4.53e-06	9.25e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—breast cancer	4.5e-06	9.19e-05	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—breast cancer	4.49e-06	9.17e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—breast cancer	4.48e-06	9.15e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP19A1—breast cancer	4.46e-06	9.12e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—STK11—breast cancer	4.46e-06	9.12e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR1—breast cancer	4.44e-06	9.08e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—TYMS—breast cancer	4.4e-06	8.99e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIF1A—breast cancer	4.38e-06	8.94e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—breast cancer	4.35e-06	8.89e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOR1—breast cancer	4.35e-06	8.88e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PLA2G4A—breast cancer	4.35e-06	8.88e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—breast cancer	4.35e-06	8.88e-05	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—breast cancer	4.31e-06	8.81e-05	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK3—breast cancer	4.25e-06	8.69e-05	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—breast cancer	4.25e-06	8.67e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CAV1—breast cancer	4.23e-06	8.65e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GPX1—breast cancer	4.17e-06	8.51e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK3—breast cancer	4.15e-06	8.48e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—COMT—breast cancer	4.15e-06	8.48e-05	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—breast cancer	4.14e-06	8.46e-05	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—breast cancer	4.14e-06	8.45e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—breast cancer	4.13e-06	8.44e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYP1A1—breast cancer	4.12e-06	8.42e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ERCC2—breast cancer	4.09e-06	8.35e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HMOX1—breast cancer	4.07e-06	8.32e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ITPR1—breast cancer	4.06e-06	8.3e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—breast cancer	4.04e-06	8.24e-05	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—breast cancer	3.99e-06	8.15e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS2—breast cancer	3.98e-06	8.13e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOTCH1—breast cancer	3.94e-06	8.05e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—breast cancer	3.91e-06	7.98e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KIT—breast cancer	3.86e-06	7.88e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—APC—breast cancer	3.86e-06	7.88e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—breast cancer	3.84e-06	7.85e-05	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—breast cancer	3.82e-06	7.8e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGF—breast cancer	3.81e-06	7.79e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—breast cancer	3.8e-06	7.75e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PLA2G4A—breast cancer	3.8e-06	7.75e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOR1—breast cancer	3.8e-06	7.75e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK3—breast cancer	3.71e-06	7.58e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GPX1—breast cancer	3.63e-06	7.42e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—breast cancer	3.62e-06	7.4e-05	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—breast cancer	3.61e-06	7.38e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—breast cancer	3.61e-06	7.37e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYP1A1—breast cancer	3.6e-06	7.35e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ERCC2—breast cancer	3.57e-06	7.29e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CAV1—breast cancer	3.55e-06	7.24e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT2—breast cancer	3.53e-06	7.21e-05	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—breast cancer	3.52e-06	7.2e-05	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—breast cancer	3.47e-06	7.09e-05	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—breast cancer	3.4e-06	6.94e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CD—breast cancer	3.39e-06	6.92e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—breast cancer	3.35e-06	6.85e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SERPINE1—breast cancer	3.35e-06	6.85e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CG—breast cancer	3.23e-06	6.6e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—breast cancer	3.2e-06	6.54e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CAV1—breast cancer	3.09e-06	6.32e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—breast cancer	3.04e-06	6.2e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—RAF1—breast cancer	3.03e-06	6.18e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ERBB2—breast cancer	2.99e-06	6.12e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—breast cancer	2.96e-06	6.05e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTOR—breast cancer	2.96e-06	6.04e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CB—breast cancer	2.96e-06	6.04e-05	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—breast cancer	2.95e-06	6.03e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—breast cancer	2.95e-06	6.02e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—breast cancer	2.93e-06	5.98e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CD—breast cancer	2.84e-06	5.8e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CG—breast cancer	2.82e-06	5.76e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—breast cancer	2.8e-06	5.72e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—breast cancer	2.77e-06	5.66e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—breast cancer	2.68e-06	5.48e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CTNNB1—breast cancer	2.62e-06	5.35e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—breast cancer	2.56e-06	5.23e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—breast cancer	2.55e-06	5.22e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CD—breast cancer	2.48e-06	5.06e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CB—breast cancer	2.47e-06	5.05e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—breast cancer	2.45e-06	5.01e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—breast cancer	2.45e-06	5e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SRC—breast cancer	2.37e-06	4.84e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—breast cancer	2.34e-06	4.78e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—breast cancer	2.28e-06	4.66e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK3—breast cancer	2.18e-06	4.46e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CB—breast cancer	2.16e-06	4.41e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—breast cancer	2.14e-06	4.37e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—breast cancer	2.14e-06	4.37e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—breast cancer	2.12e-06	4.33e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—breast cancer	2.12e-06	4.32e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—breast cancer	2.08e-06	4.24e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—breast cancer	1.96e-06	4e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—breast cancer	1.87e-06	3.81e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—breast cancer	1.8e-06	3.68e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—breast cancer	1.67e-06	3.4e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—breast cancer	1.6e-06	3.26e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—breast cancer	1.51e-06	3.08e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—breast cancer	1.47e-06	3.01e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—breast cancer	1.32e-06	2.69e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—breast cancer	1.23e-06	2.52e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—breast cancer	1.08e-06	2.2e-05	CbGpPWpGaD
